Britain's competition watchdog has imposed legally binding price controls and transparency requirements on the veterinary sector, after finding that animal care costs had been rising at nearly twice the rate of inflation. The measures — capping prescription fees, mandating written estimates, and requiring disclosure of cheaper drug alternatives — reflect a broader reckoning with what happens when a profession built on care becomes shaped by market consolidation. As with many regulatory interventions, the rules may protect consumers in one hand while quietly concentrating power in the other.